Malignant Large Intestinal Neoplasm — Research

Malignant Large Intestinal Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	486	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	7	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	1	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (370)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 276–300 of 370 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer.
· Scand J Gastroenterol · 2014 · PMID 24256029 · validated civic_curation pubmed
HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab.
· Ann Oncol · 2013 · PMID 24146218 · validated civic_curation pubmed
Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer.
· J Cancer Res Clin Oncol · 2016 · PMID 27177629 · validated civic_curation pubmed